Heparin and the Reduction of Thrombosis (HART) Trial

Trial ID or NCT#

NCT00779558

Status

not recruiting iconNOT RECRUITING

Purpose

Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?

Official Title

Heparin and Catheter-related Thrombosis in Neonates and Infants Following Cardiac Surgery

Eligibility Criteria

Ages Eligible for Study: 1 Day to 1 Year
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - All infants < 1 year of age undergoing cardiac surgery at Lucile Packard Children's Hospital & #xA
Exclusion Criteria:
  1. - Known coagulopathy - History of clinically significant bleeding (GI, cranial, pulmonary) - Need for therapeutic heparinization - ECMO
View All Criteria
Show Less

Investigator(s)

Stephen J. Roth
David M. Axelrod, MD

Contact us to find out if this trial is right for you.

Contact

David Axelrod
4156072463

View on ClinicalTrials.gov